NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/11/2024
Voltar para busca
Dado oficial do USPTO
LEITERS HEALTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LEITERS HEALTH
ST13
US500000097087362Classe
5, 9, 35, 39, 41, 42, 44
Pedido
97087362
Registro
7580430
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
26/11/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 35, 39, 41, 42, 44
Data de depósito
22/10/2021
Data de registro
26/11/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/11/2024
Última transação
26/11/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
15/11/2023
Primeiro uso no comércio
15/11/2023
Código do desenho
4
Tipo de titular
03
Localização do titular
Englewood, CO
Examinador
MACDOUGALL, KIERRA
Unidade examinadora
N80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
LEITERS, INC.
Representantes
Janet M. Garetto NIXON PEABODY LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 35Classe 39Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Syringes sold filled with medication for treating a wide variety of conditions and illnesses; Intravenous bags sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Vials sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Medication reservoirs and cassettes sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses; Medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time which are sold filled with medication, namely, antibiotics, anticoagulants, antiemetics, cardio vascular drugs, epidural drugs, local anesthesia drugs, ophthalmology drugs, ophthalmics drugs, and pain management drugs for treating a wide variety of conditions and illnesses
Classe 9
Downloadable electronic publications, namely, brochures, magazines and newsletters in the field of training and/or continuing education for compounding pharmacists
Classe 35
Pharmacy outsourcing services; pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Central fill pharmacy services
Classe 39
Packaging and repackaging of pharmaceutical products for human use to the order and specification of others
Classe 41
Providing a blog website featuring non-downloadable publications in the nature of brochures, magazines, newsletters and articles regarding training and/or continuing education for compounding pharmacists in the fields of pharmaceuticals and/or pharmaceutical compounding; Non-downloadable electronic publications in the nature of brochures, magazines and newsletters in the field of training and/or continuation education for compounding pharmacists
Classe 42
Development of pharmaceutical preparations and medicines
Classe 44
Pharmaceutical compounding services
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
26/11/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/11/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/11/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
26/09/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
26/09/2024
IUAF
USE AMENDMENT FILED
25/07/2024
EISU
TEAS STATEMENT OF USE RECEIVED
25/07/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/12/2023
EX1G
SOU EXTENSION 1 GRANTED
05/12/2023
EXT1
SOU EXTENSION 1 FILED
05/12/2023
EEXT
SOU TEAS EXTENSION RECEIVED
05/12/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
25/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/05/2023
PUBO
PUBLISHED FOR OPPOSITION
30/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/03/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/09/2022
GNRT
NON-FINAL ACTION E-MAILED
13/09/2022
CNRT
NON-FINAL ACTION WRITTEN
13/09/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/09/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
23/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/08/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
09/08/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/08/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
09/08/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/08/2022
DOCK
ASSIGNED TO EXAMINER
01/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/11/2021
NWAP
NEW APPLICATION ENTERED
26/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LEITERS HEALTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.